Persons holding the authorisation provided for in article R. 5132-74 are required to draw up an annual statement indicating for each narcotic drug:
1° The quantities received ;
2° The quantities used for manufacture or processing, indicating the nature and quantity of the products obtained as well as any losses resulting from these operations;
3° Quantities disposed of;
4° Year-end stocks, including stocks of products in the process of being processed.
This statement, which covers the previous calendar year, is sent to the Agence nationale de sécurité du médicament et des produits de santé by 15 February at the latest.
The authorisation provided for in Article R. 5132-74 may require its holder to draw up and produce several summary statements during each calendar year.
In addition, the establishments mentioned in 5° of Article R. 5124-2 are required, at the request of the Director General of the Agence nationale de sécurité du médicament et des produits de santé, to transmit the quantities sold on a monthly basis.
This statement is also sent to the Agency by the services, establishments and organisations mentioned in 3° bis and 3° ter of I and II of Article R. 5132-76.